Eurofins Scientific is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and for supporting clinical studies as well as one of the leading global emerging players in specialty clinical diagnostic testing.
Eurofins Biomnis Middle East LLC Company Profile
As a central element in healthcare, clinical diagnostics contributes toevery stage of patient care: predisposition, prevention, diagnostics, treatment monitoring and prognosis.
Genetics and genomics are gradually marking out the new outlines of tomorrow‘s clinicaldiagnosticsand our labs are investing heavily in advanced genetic technologies.
Eurofins Clinical diagnostics has global outreach with presence in 335 locations across the world.
Eurofins Clinical Diagnostics has a broad portfolio of genetic tests with well-knownapplications such as Non Invasive Prenatal Testing (NIPT), the screening of hereditary cancers, cardiovascular disease predisposition, rare diseases diagnosis, and personalized medicine applications that can offer patients individualized treatment based on their genetic and metabolic profiles.
Eurofins Biomnis Middle East LLC is our new entity created in October 2019 (post acquisition of DowDiagnostics Dubai) to service the entire Middle East region, including United Arab Emirates, Saudi Arabia, Kuwait, Oman and Bahrain. The services are provided from 4 primary labs (CAP / ISO accredited) located in Dubai, Paris, Lyon & Bangalore.
We have in-house Comprehensive coverage of all the departments of pathology
Histopathology and Cytopathology